Kamada (KMDA) Director Dekel Benjamin Receives Stock Awards

What Happened
Director Dekel Benjamin was granted option-based awards covering a total of 46,000 ordinary shares (16,000 + 30,000) on August 27, 2026. The awards are reported as derivative acquisitions with an acquisition price to the insider of $0.00 (awarded options rather than an open‑market purchase). The filing shows these as awards under the company’s share award plan and does not report any immediate cash value realized on grant.

Key Details

• Transaction date: August 27, 2026 (Form 4 filed September 23, 2026 — filing was late).
• Award totals: 16,000 and 30,000 option awards (46,000 total). Reported acquisition price: $0.00 (grant).
• Vesting & term: Options vest 25% per year over 4 years and are exercisable for 10 years from grant (per footnote).
• Hold/plan: Awards are held by a trustee under the Company’s 2011 Share Award Plan.
• Exercise-price adjustment: The exercise prices were adjusted in connection with a special cash dividend (record date Aug 27, 2026); these options were previously reported at $6.27 (16k) and $7.55 (30k) before adjustment. Exercise prices in the filing are shown in USD using the Bank of Israel exchange rate as of Sep 22, 2026.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Filing timeliness: This Form 4 was filed roughly a month after the grant date and is marked late — potential reporting compliance issue (does not by itself indicate trading intent).

Context
These are compensation awards (derivative option grants) intended for retention/incentive and are not open‑market purchases or sales. They will only translate into stock ownership if and when the options vest and are exercised (and any applicable taxes are satisfied). Awards adjusted for a special dividend reflect standard post‑dividend exercise price mechanics; the grant itself does not indicate immediate buying or selling activity.